BusinessZIVO Bioscience and Tianjin Norland Biotech Execute Letter of Intent to Produce ZIVO Algae Strain in China for International and Domestic MarketsBy Nasdaq OMXFeb 1, 2018, 12:52 PM UTC
BusinessZIVO Bioscience Subsidiary Wellmetris Selected to Present at Biotech Showcase During JPMorgan Healthcare Conference Jan 7-10 in San Francisco, CABy Nasdaq OMXJan 8, 2018, 1:03 PM UTC
BusinessEarth Science Tech, Inc. Shares New Innovative CBD Product Revamp, Marking Plan, & Product/Brand Education StrategyBy Nasdaq OMXDec 7, 2017, 1:01 PM UTC
BusinessZIVO Bioscience, Inc. Kicks Off Final Phase of Bovine Mastitis StudyBy Nasdaq OMXSep 11, 2017, 12:01 PM UTC
BusinessZIVO Bioscience, Inc. Executes Definitive Agreement With NutriQuest, Commences Poultry Field TrialBy Nasdaq OMXApr 26, 2017, 8:36 PM UTC
